Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

7 Robinhood Stocks You Shouldn’t Touch With a 10-Foot Pole

By Faisal Humayun, InvestorPlace Contributor
These Robinhood stocks look fundamentally weak and are positioned for downside. They are likely to disappoint even in a bull market.

GameStop Remains a Poor Way to Play Retail Stocks

By Will Ashworth, InvestorPlace Contributor
GameStop’s push into e-commerce is an argument for why to buy. However, if you’re looking for a retailer to own, GME stock is not it. 

Fear the Wild Rally and Keep Your Distance from Upstart

By David Moadel, InvestorPlace Contributor
A big-bank analyst double downgrade is just one sign that too much future success has already been priced into UPST stock.

Camber Energy Has Nothing to Turn Its Fortunes Around

By Muslim Farooque, InvestorPlace Contributor
Oil and Gas meme stock Camber Energy has no real growth drivers to transform it and push CEI stock higher after the Kerrisdale report.

Lemonade Stock Is a Sweet Idea with Sour Finances Sending Up Red Flags

By Marie Brodbeck, InvestorPlace Contributor
LMND stock appeals as a potential disruptor, particularly considering it's appeal to the younger generation. But it's not all sweet when it comes to the group's finances and path to profitability.

Without Profits, Cloudflare Stock Is Too Expensive No Matter What

By Stavros Georgiadis, CFA, InvestorPlace Contributor
It might be tempting to look at NET stock and imagine it would be worth buying if it just dropped a bit, but that's not true without profit.

Avoid Farmmi After It Diluted Shares Twice to Expand Its Business

By Stavros Georgiadis, CFA, InvestorPlace Contributor
In addition to two dilutive public offerings, FAMI stock carries several other risks that outweigh the potential benefits of its expansion.

Microvision Investors Can Forget Self-Driving Cars for Now

By Dana Blankenhorn, InvestorPlace Contributor
Microvision has no product revenue, just patent royalties that brought in less than $1 million in its most recent quarter. So why is it worth $1.5 billion?

SoFI Technologies Stock Won’t Reach $25 This Year

By Alex Sirois, InvestorPlace Contributor
SOFI stock received a nod from Wall Street, but real challenges actually lie ahead for the loan originator.

It’s Time to Secure Those Profits You Earned from Novavax

By Josh Enomoto, InvestorPlace Contributor
While NVAX stock had an excellent run, the vaccination market is practically saturated, meaning investors should consider profit-taking.

Hyliion Holdings Stock Isn’t as Cheap as It Looks as Costs Rise and Hope Fades

By Alex Sirois, InvestorPlace Contributor
Trouble continues to compound for HYLN stock as SPAC hype fades. The company is predicting much greater results than anyone else.

UiPath Is Losing Money on a Cash Flow Basis Leaving It Lost In Its Way

By Mark R. Hake, CFA
PATH stock is likely to take another 33% drop to at least $33.59, as its overvalued price-to-sales multiple deflates.

Olaplex Is Overvalued As None of the IPO Proceeds Go to the Company

By Mark R. Hake, CFA
Olaplex is overvalued as none of the IPO proceeds go to the company. Investors will see through the actions of the private equity fund and value OLPX stock significantly lower.

This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short

By Thomas Niel, InvestorPlace Contributor
Highly volatile, with a tendency to make unwarranted moves higher, it's best to not go long (or short) OCGN stock.

CrowdStrike Stock Has Had Its Run, But There Are Much Better Security Plays

By Larry Ramer, InvestorPlace Contributor
CrowdStrike has many positive attributes, including strong partners and a rapidly growing business. But the valuation of CRWD stock is very high.

Nothing Suggests Hyliion Stock Can Charge Back Up to Past Prices

By Louis Navellier and the InvestorPlace Research Staff
As it falls short of expectations, and with more signs of it floundering further, it's best to stay away from HYLN stock.

WISH Stock Is a Bad Risk in a Sea of Better Speculative Growth Bets

By Wayne Duggan, InvestorPlace Contributor
Wish.com parent company ContextLogic (NASDAQ:WISH) stock has been a disaster since its initial public offering. Wish went public at an IPO price of $24 in…

China’s President Is the X Factor for Alibaba Stock

By Larry Ramer, InvestorPlace Contributor
The heavy-handedness and unpredictability of China's president, Xi Jinping, makes BABA stock too risky, even after its shares have fallen meaningfully.

Ocugen Is a Strong Sell, Vaccine Unlikely to Find Commercial Success

By Ian Bezek, InvestorPlace Contributor
Ocugen has historically had a terrible track record. There's little reason to think its current vaccine effort will end any better for OCGN stock.
Load More Articles